Crystal structure and Hirshfeld surface analysis of
(3S,3aR,6aS )-3-(1,3-diphenyl-1H-pyrazol-4-yl)-5-(4-methoxyphenyl)-
2-phenyl-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-
d ][1,2]oxazole-4,6-dione
Oxazole scaffold compounds currently find application in
medicinal drugs such as Aleglitazar (antidiabetic), Ditazole
(platelets aggregation inhibitor), Mubritinib (tyrosine kinase
inhibitor), and Oxaprozin (COX-2 inhibitor) (Kakkar et al.,
2018). In addition they show anti-microbial (Tomi et al., 2015)
and anti-cancer (Liu et al., 2009) activity.In this context, we
determined the crystal structure of the title compound